Cronos Group (NASDAQ:CRON) Stock Rating Lowered by Wall Street Zen

Cronos Group (NASDAQ:CRON – Get Free Report) was downgraded by equities researchers at Wall Street Zen from a “buy” rating to a “hold” rating in a research note issued on Saturday, Wall Street Zen reports.

A number of other equities analysts also recently commented on the stock. Weiss Ratings upgraded shares of Cronos Group from a “buy (b-)” rating to a “buy (b)” rating in a research note on Thursday, October 8th. TD Securities reaffirmed a “buy” rating on shares of Cronos Group in a research report on Monday, September 28th. Finally, Zacks Research upgraded Cronos Group from a “hold” rating to a “strong-buy” rating in a report on Thursday, October 22nd. One equities research analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating and one has assigned a Hold rating to the company. According to MarketBeat.com, the stock has an average rating of “Buy” and an average price target of $2.30.

Get Our Latest Report on Cronos Group

Cronos Group Stock Down 1.3%

Cronos Group stock opened at $3.04 on Friday. The stock has a market capitalization of $1.11 billion, a PE ratio of 40.88 and a beta of 0.96. Cronos Group has a twelve month low of $2.28 and a twelve month high of $3.91. The company has a 50 day moving average of $3.32 and a 200-day moving average of $2.91.

Cronos Group (NASDAQ:CRON – Get Free Report) last posted its quarterly earnings data on Thursday, November 5th. The company reported $0.04 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.03 by $0.01. Cronos Group had a return on equity of 2.56% and a net margin of 28.04%. The business had revenue of $63.45 million during the quarter, compared to the consensus estimate of $51.15 million. Equities analysts anticipate that Cronos Group will post 0.16 EPS for the current fiscal year.

Institutional Investors Weigh In On Cronos Group

Hedge funds have recently bought and sold shares of the stock. Goldman Sachs Group Inc. grew its position in shares of Cronos Group by 23.5% in the third quarter. Goldman Sachs Group Inc. now owns 671,031 shares of the company’s stock valued at $2,214,000 after purchasing an additional 127,795 shares during the last quarter. Jump Financial LLC acquired a new stake in Cronos Group during the 3rd quarter worth approximately $234,000. State Street Corp acquired a new stake in Cronos Group during the 3rd quarter worth approximately $404,000. Private Advisor Group LLC boosted its stake in Cronos Group by 10.0% in the 3rd quarter. Private Advisor Group LLC now owns 32,681 shares of the company’s stock valued at $108,000 after purchasing an additional 2,984 shares during the period. Finally, HighTower Advisors LLC bought a new stake in Cronos Group in the 3rd quarter valued at $1,198,000. 8.71% of the stock is currently owned by institutional investors and hedge funds.

Cronos Group Company Profile

(Get Free Report)

Cronos Group is a cannabinoid company that develops, produces, and markets cannabis and cannabis-derived products. Its business includes cultivation, processing, product development, and distribution. The company sells products in categories such as dried cannabis flower, pre-rolls, vaporizers, edibles, and extracts. Its brand portfolio includes Spinach and PEACE NATURALS. Founded in 2012 and headquartered in Toronto, Cronos serves consumers in Canada and select international markets, including Israel.

Featured Stories

Analyst Recommendations for Cronos Group (NASDAQ:CRON)

Receive News & Ratings for Cronos Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cronos Group and related companies with MarketBeat.com's FREE daily email newsletter.